Hydromorphone Hydrochloride
NDC 13811-702, Hydromorphone Hydrochloride, tablet, extended release, from Trigen Laboratories, LLC.
- Product NDC
- 13811-702
- Status
- Listed
- Labeler
- Trigen Laboratories, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205629
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/13811-702 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDROMORPHONE HYDROCHLORIDE12 mg/1
Pharmacologic classes
Full Opioid Agonists [MoA]; Opioid Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 13811-702-10 | 13811070210 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13811-702-10) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/8bb81796-6990-40e9-bee4-1f292f91ae99NADAC price for package 13811070210
GET /v1/drugs/nadac/13811070210
Use it
Look up 13811-702 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/13811-702 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 13811-702. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.